ClinicalTrials.gov
public full text
Public Domain
First in Human Study of T3P-Y058-739 (T3P)
This is a first in human, phase I/II open-label, dose-finding, safety, and proof-of-concept clinical trial of T3P-Y058-739, a genetically-modified, live attenuated strain of the bacterium Yersinia enterocolitica, in patients with advanced solid tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Core-genome typing links Yersinia enterocolitica isolated from pigs and cattle to human infections in France#121865
- Phase 1 Study of DS-8895a in Subjects With Advanced Solid Tumors#915282
- Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms#835852
- Class 3 Biowaivers#892050
- Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs#1125437
Record · ID 854739
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive